ES2128441T3 - Empleo de toremifeno para tratar sle. - Google Patents

Empleo de toremifeno para tratar sle.

Info

Publication number
ES2128441T3
ES2128441T3 ES93923058T ES93923058T ES2128441T3 ES 2128441 T3 ES2128441 T3 ES 2128441T3 ES 93923058 T ES93923058 T ES 93923058T ES 93923058 T ES93923058 T ES 93923058T ES 2128441 T3 ES2128441 T3 ES 2128441T3
Authority
ES
Spain
Prior art keywords
toremifeno
treat sle
sle
treat
glucocorticoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93923058T
Other languages
English (en)
Inventor
Junpei Itoh
Osamu Miyazaki
Hisao Ekimoto
Michinori Koyama
Tetsushi Saino
Lauri Kangas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Nippon Kayaku Co Ltd
Original Assignee
Orion Yhtyma Oy
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy, Nippon Kayaku Co Ltd filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of ES2128441T3 publication Critical patent/ES2128441T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

SE PRESENTA EL USO DE COMPUESTOS ANTI-ESTROGENOS NO ESTEROIDALES TALES COMO EL CITRATO DE TOROMIFENO COMO INGREDIENTE ACTIVO PARA EL TRATAMIENTO DE LAS ENFERMEDADES AUTOINMUNES.
ES93923058T 1992-10-27 1993-10-26 Empleo de toremifeno para tratar sle. Expired - Lifetime ES2128441T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31077292 1992-10-27

Publications (1)

Publication Number Publication Date
ES2128441T3 true ES2128441T3 (es) 1999-05-16

Family

ID=18009292

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93923058T Expired - Lifetime ES2128441T3 (es) 1992-10-27 1993-10-26 Empleo de toremifeno para tratar sle.

Country Status (12)

Country Link
US (3) US6355688B1 (es)
EP (2) EP0667768B1 (es)
KR (1) KR100303634B1 (es)
CN (1) CN1053337C (es)
AT (1) ATE177008T1 (es)
AU (1) AU5286693A (es)
DE (1) DE69323759T2 (es)
DK (1) DK0667768T3 (es)
ES (1) ES2128441T3 (es)
GR (1) GR3029682T3 (es)
NO (2) NO314533B1 (es)
WO (1) WO1994009764A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US5521198A (en) * 1993-12-21 1996-05-28 Eli Lilly And Company Methods of inhibiting autoimmune diseases
CA2280181A1 (en) * 1997-02-09 1998-08-13 Pharmos Corporation Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
JP2002501624A (ja) 1997-03-06 2002-01-15 ナシュア コーポレイション 偏光維持拡散シートを用いたディスプレイ
US8278291B1 (en) 1999-08-13 2012-10-02 Curadis Gmbh Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US7069444B2 (en) * 2002-01-25 2006-06-27 Brent A. Lowensohn Portable wireless access to computer-based systems
WO2009149081A1 (en) * 2008-06-02 2009-12-10 Novelmed Therapeutics, Inc. Method for treating inflammatory conditions
MX2011008406A (es) 2009-02-09 2012-01-12 Valspar Sourcing Inc Sistema de pintura y tiene no absorbente de radiacion infrarroja coloreable en tienda.
AU2010210344B2 (en) 2009-02-09 2016-02-25 Swimc Llc In-store tintable non-infrared-absorptive paint and stain system
CN103154154B (zh) 2010-07-01 2016-02-17 威士伯采购公司 红外反射性双组份涂料组合物
MY161750A (en) 2010-10-20 2017-05-15 Valspar Sourcing Inc Water-based coating system with improved moisture and heat resistance
RU2572504C1 (ru) * 2013-12-26 2016-01-10 Андрей Константинович Иорданишвили Способ лечения лучевой сиалоаденопатии
MA43805A (fr) 2016-02-23 2018-11-28 Advanced Environmental Recycling Tech Inc Compositions et procédés pour réduire la température de surface d'articles composites
EP3562682A1 (en) 2017-01-01 2019-11-06 Advanced Environmental Recycling Technologies, Inc Methods for coating composite articles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172948B (hu) 1976-02-05 1979-01-28 Gyogyszerkutato Intezet Sposob poluchenija osnovnykh proizvodnykh trifenil-alkenov
DE2860900D1 (en) 1977-08-22 1981-11-05 Ici Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
DE3046719C2 (de) 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
FI67538C (fi) 1982-05-27 1985-04-10 Farmos Oy Foerfarande foer framstaellning av (z)-1,2-difenyl-1-(4-(2-(n n-dimetylamino)etoxi)fenyl)-1-buten
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
US5348729A (en) * 1988-11-30 1994-09-20 The United States Of America As Represented By The Department Of Health And Human Services Evaluative means for detecting inflammatory reactivity
US4990538A (en) * 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
JPH04312526A (ja) * 1991-04-09 1992-11-04 Fujisawa Pharmaceut Co Ltd 骨疾患治療剤

Also Published As

Publication number Publication date
NO317544B1 (no) 2004-11-08
DE69323759D1 (de) 1999-04-08
AU5286693A (en) 1994-05-24
NO314533B1 (no) 2003-04-07
WO1994009764A1 (en) 1994-05-11
EP0667768B1 (en) 1999-03-03
US6458848B1 (en) 2002-10-01
NO951596L (no) 1995-04-26
US20020107231A1 (en) 2002-08-08
US6355688B1 (en) 2002-03-12
CN1100930A (zh) 1995-04-05
EP0776661A1 (en) 1997-06-04
NO951596D0 (no) 1995-04-26
DK0667768T3 (da) 1999-09-27
KR100303634B1 (ko) 2001-11-22
NO20025179D0 (no) 2002-10-28
ATE177008T1 (de) 1999-03-15
KR940008677A (ko) 1994-05-16
GR3029682T3 (en) 1999-06-30
EP0667768A1 (en) 1995-08-23
DE69323759T2 (de) 1999-07-22
NO20025179L (no) 1995-04-26
CN1053337C (zh) 2000-06-14
US6387958B1 (en) 2002-05-14

Similar Documents

Publication Publication Date Title
ES2128441T3 (es) Empleo de toremifeno para tratar sle.
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
HK1003978A1 (en) Composition for the treatment of schizophrenia
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
PT814796E (pt) Uso de um farmaco r-aine numa composicao protectora para o tratamento do cancro colorectal
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
BR8900357A (pt) Composicao e processo de tratamento de tecido e processo para a preparacao da dita composicao
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
ZA896150B (en) The use of alpha-amino boronic acid derivatives for the prophylaxis and treatment of virus diseases
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
MX9304185A (es) Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina.
BR9612206A (pt) Composto uso do composto composição farmacêutica processo para preparação do composto e para o tratamento da dor
GR82545B (en) Pharmaceutical preparation for treating rheumatics
BR9302734A (pt) Processo para a prepparacao e purificacao de uma solucao de sal de hidroxilamonio
BR9510250A (pt) Sal de diclavulanato processo para preparar sal de ácido clavulânico e composição farmacêutica
ATE181669T1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
HUP9802314A3 (en) Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
IT1254256B (it) Derivati di idroisochinolina
TW207496B (en) Pharmaceutical composition for preventing or delaying the occurrence of dementia
IT1264335B (it) Uso topico di composizioni farmaceutiche a base di piricarbato nel trattamento delle alopecie primitive o secondarie e della psoriasi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 667768

Country of ref document: ES